Asset Details
Do you wish to reserve the book?
DNA methylation in cord blood in association with prenatal depressive symptoms
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
DNA methylation in cord blood in association with prenatal depressive symptoms
Do you wish to request the book?
DNA methylation in cord blood in association with prenatal depressive symptoms
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
DNA methylation in cord blood in association with prenatal depressive symptoms
2021
Overview
Background
Prenatal symptoms of depression (PND) and anxiety affect up to every third pregnancy. Children of mothers with mental health problems are at higher risk of developmental problems, possibly through epigenetic mechanisms together with other factors such as genetic and environmental. We investigated DNA methylation in cord blood in relation to PND, taking into consideration a history of depression, co-morbidity with anxiety and selective serotonin reuptake inhibitors (SSRI) use, and stratified by sex of the child. Mothers (
N
= 373) prospectively filled out web-based questionnaires regarding mood symptoms and SSRI use throughout pregnancy. Cord blood was collected at birth and DNA methylation was measured using Illumina MethylationEPIC array at 850 000 CpG sites throughout the genome. Differentially methylated regions were identified using Kruskal–Wallis test, and Benjamini-Hochberg adjusted
p
-values < 0.05 were considered significant.
Results
No differential DNA methylation was associated with PND alone; however, differential DNA methylation was observed in children exposed to comorbid PND with anxiety symptoms compared with healthy controls in
ABCF1
(log twofold change − 0.2), but not after stratification by sex of the child. DNA methylation in children exposed to PND without SSRI treatment and healthy controls both differed in comparison with SSRI exposed children at several sites and regions, among which hypomethylation was observed in CpGs in the promoter region of
CRBN (
log2 fold change − 0.57), involved in brain development, and hypermethylation in
MDFIC
(log2 fold change 0.45), associated with the glucocorticoid stress response.
Conclusion
Although it is not possible to assess if these methylation differences are due to SSRI treatment itself or to more severe depression, our findings add on to existing knowledge that there might be different biological consequences for the child depending on whether maternal PND was treated with SSRIs or not.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V
Subject
/ Analysis
/ Anxiety
/ Biomedical and Life Sciences
/ CBCL
/ Children
/ Depressive Disorder - genetics
/ Depressive Disorder - psychology
/ DNA
/ Emotions
/ EPDS
/ EWAS
/ Female
/ Genomes
/ Genomics
/ Humans
/ Male
/ Pregnancy Complications - genetics
/ Pregnancy Complications - psychology
/ Prenatal depressive symptoms
/ Prenatal Exposure Delayed Effects - genetics
/ Prenatal Exposure Delayed Effects - psychology
/ Women
